- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02564328
Autologous Bone Marrow Mesenchymal Stem Cell Transplantation for Chronic Ischemic Stroke
September 29, 2015 updated by: Xiaodan Jiang, Southern Medical University, China
Stroke is a frequently occurring and common diseases in nervous system,and most of the survivors will remain disorders of motor,sensory and cognition function.Stem cell transplantation provides a promising approach for rehabilitation.
The main objective of this study is to evaluate the efficacy and safy of the transplantation of autologous bone marrow mesenchymal stem cells in patients with chronic stroke.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Stroke is a frequently occurring and common diseases in nervous system,and most of the survivors will remain disorders of motor,sensory and cognition function.It will brought heavy burden to patients themselves,their family and society.Drugs,rehabilitation excise and hyperbaric oxygen will improve functions after acute stroke.However,in the chronic ischemic stroke,there was few methods to improve the functions.In recently research,stem cell will be a new methods to improve the neural function after through differentiate to nervous cells and secrete some neurotrophic factors to repair the damage.
In this study, the investigators will assess the safety and feasibility of intracerebral transplantation of autologous bone marrow mesenchymal stem cells in patients with chronic ischemic stroke.
The neurological outcome will be determined after transplantation.
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Xiaodan Jiang, MD,PhD
- Phone Number: 86 20 61643268
- Email: jiangxiao_dan@163.com
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510282
- Recruiting
- Xiaodan Jiang
-
Contact:
- Xiaodan Jiang, MD,PhD
- Phone Number: 86 20 61643268
- Email: jiangxiao_dan@163.com
-
Principal Investigator:
- Xiaodan Jiang, MD,PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Aged 18-80 chronic ischemia stroke or patients
- With stroke history of more than 6 months, less than 60 months
- NIHSS (NIH stroke scale) score of 7 or more points
- Internal carotid artery territory infarction measured by MRI
- Can be hospitalized and signed informed consent
- With fewer effect by traditional post-stroke treatments or rehabilitations
Exclusion Criteria:
- Lacunar infarction
- Recurrent thrombotic diseases less than 6 months
- Hemorrhage stroke,brain tumor or MRI show the occlusion is not in the middle cerebral artery territory
- Pregnant women
- Can't tolerate the test because of other disease, such as heart failure, liver failure, renal failure, abnormal blood coagulation, AIDS, combine other tumor or special condition
- Penicillin anaphylaxis or some other drugs allergy
- Autoimmune disease
- Inaccessibility for follow up
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Intravenous stem cell transplantation
Intravenous transplantation of autologous bone marrow mesenchymal stem cell plus conventional treatment include rehabilitation
|
Intravenous injection of autologous bone marrow mesenchymal stem cell transplantation
|
No Intervention: Conventional treatment
Control group receive conventional stroke treatment that include rehabilitation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change from baseline in Fugl-Meyer Scale at 12 months
Time Frame: 1,3,6 and 12 months
|
1,3,6 and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change from baseline in NIH Stroke Scale at 12 months
Time Frame: 1,3,6 and 12 months
|
1,3,6 and 12 months
|
Change from baseline in Barthel Index at 12 months
Time Frame: 1,3,6 and 12 months
|
1,3,6 and 12 months
|
Change from baseline in SSS at 12 months
Time Frame: 1,3,6 and 12 months
|
1,3,6 and 12 months
|
Change from baseline in mRS at 12 months
Time Frame: 1,3,6 and 12 months
|
1,3,6 and 12 months
|
Improvement of vision measured by brain visual examination
Time Frame: 1,6 and 12 months
|
1,6 and 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Xiaodan Jiang, MD,PhD, Southern Medical University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2014
Primary Completion (Anticipated)
November 1, 2016
Study Completion (Anticipated)
November 1, 2017
Study Registration Dates
First Submitted
September 29, 2015
First Submitted That Met QC Criteria
September 29, 2015
First Posted (Estimate)
September 30, 2015
Study Record Updates
Last Update Posted (Estimate)
September 30, 2015
Last Update Submitted That Met QC Criteria
September 29, 2015
Last Verified
September 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201400000003-2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on Intravenous stem cell transplantation
-
Southern Medical University, ChinaSecond Affiliated Hospital of Guangzhou Medical UniversityCompleted
-
Children's Hospital of Chongqing Medical UniversityUnknown
-
Royan InstituteCompletedMultiple SclerosisIran, Islamic Republic of
-
Northwestern UniversityTerminated
-
National Heart Institute, MexicoNational Center of Blood Transfusion Mexico.UnknownAcute Myocardial InfarctionMexico
-
General Hospital of Chinese Armed Police ForcesWithdrawn
-
Wake Forest University Health SciencesCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...WithdrawnAnemia | Thrombocytopenia | Neutropenia | Hematopoietic/Lymphoid Cancer | Lymphopenia
-
Royan InstituteCompletedOsteoarthritisIran, Islamic Republic of
-
Daping Hospital and the Research Institute of Surgery...Children's Hospital of Chongqing Medical University; Chongqing Maternal and...Withdrawn